- Report
- August 2022
- 40 Pages
United States
From €1374EUR$1,500USD£1,170GBP
- Report
- August 2022
- 40 Pages
Argentina
From €1374EUR$1,500USD£1,170GBP
- Report
- August 2022
- 80 Pages
Africa
From €1832EUR$2,000USD£1,559GBP
- Report
- December 2022
- 35 Pages
Global
From €1832EUR$2,000USD£1,559GBP
- Report
- October 2022
- 1127 Pages
Global
From €2290EUR$2,500USD£1,949GBP
- Report
- October 2022
- 548 Pages
Global
From €2290EUR$2,500USD£1,949GBP
- Report
- October 2022
- 47 Pages
Global
From €3205EUR$3,500USD£2,729GBP
- Report
- October 2022
- 53 Pages
Global
From €3205EUR$3,500USD£2,729GBP
- Report
- July 2022
- 100 Pages
Global
From €3205EUR$3,500USD£2,729GBP
- Report
- April 2022
- 207 Pages
Global
From €1832EUR$2,000USD£1,559GBP
- Report
- May 2022
- 65 Pages
Global
From €2290EUR$2,500USD£1,949GBP
- Report
- May 2022
- 35 Pages
Global
From €2290EUR$2,500USD£1,949GBP
- Report
- May 2022
- 219 Pages
Global
From €3205EUR$3,500USD£2,729GBP
- Report
- February 2025
- 90 Pages
Russia, India, China, ... Russia, India, China, Brazil
From €5490EUR$5,995USD£4,674GBP
- Report
- December 2024
- 32 Pages
Brazil
From €4575EUR$4,995USD£3,895GBP
- Report
- December 2024
- 30 Pages
Mexico
From €4575EUR$4,995USD£3,895GBP
- Report
- December 2024
- 31 Pages
Japan
From €4575EUR$4,995USD£3,895GBP
- Report
- December 2024
- 32 Pages
China
From €4575EUR$4,995USD£3,895GBP
- Report
- December 2024
- 30 Pages
South Korea
From €4575EUR$4,995USD£3,895GBP
- Report
- December 2024
- 31 Pages
Russia
From €4575EUR$4,995USD£3,895GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more